CytoDyn Inc. (CYDY) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$3.70M2012: -$7.46M2013: -$7.99M2014: -$8.11M2015: -$19.60M2016: -$21.18M2017: -$27.33M2018: -$45.92M2019: -$55.85M2020: -$74.65M2021: -$104.60M2022: -$145.40M2023: -$40.58M2024: -$18.06M2025: $9.66M$9.66M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$9.66M+153.5%
2024-$18.06M+55.5%
2023-$40.58M+72.1%
2022-$145.40M-39.0%
2021-$104.60M-40.1%
2020-$74.65M-33.7%
2019-$55.85M-21.6%
2018-$45.92M-68.0%
2017-$27.33M-29.1%
2016-$21.18M-8.1%
2015-$19.60M-141.6%
2014-$8.11M-1.5%
2013-$7.99M-7.2%
2012-$7.46M-101.6%
2011-$3.70M